Pernilla Abrahamsson
Direttore operativo presso LIPUM AB
Profilo
Pernilla Abrahamsson is the founder of MD Biomedical AB.
She is currently the Chief Operating Officer at Lipum AB.
Previously, she worked as Manager-Product Development at Senzime AB from 2018 to 2019.
Dr. Abrahamsson obtained a doctorate degree from Umea Universitet.
Posizioni attive di Pernilla Abrahamsson
| Società | Posizione | Inizio |
|---|---|---|
| LIPUM AB | Direttore operativo | 01/01/2019 |
Precedenti posizioni note di Pernilla Abrahamsson
| Società | Posizione | Fine |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 01/04/2019 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Fondatore | - |
Formazione di Pernilla Abrahamsson
| Umea Universitet | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SENZIME AB | Health Technology |
| LIPUM AB | Health Technology |
| Aziende private | 1 |
|---|---|
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Part of Senzime AB, MD Biomedical AB provides micro dialysis products and services. The company is based in Umeå, Sweden. The Swedish company was founded in 2011 by Pernilla Abrahamsson. MD Biomedical was acquired by Senzime AB on April 21, 2015 for $0.24 million. | Health Services |
- Borsa valori
- Insiders
- Pernilla Abrahamsson
